Moving beyond single targets in neurological repair Neuro-Innovators is testing whether a combination of existing medicines can promote neuroplasticity and improve outcomes for people living with chronic stroke disability. Written byBree Foster, PhD

Moving beyond single targets in neurological repair Neuro-Innovators is testing whether a combination of existing medicines can promote neuroplasticity and improve outcomes for people living with chronic stroke disability. Written byBree Foster, PhD https://www.drugdiscoverynews.com/moving-beyond-single-targets-in-neurological-repair-17486?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-84vh7nMnqBm_u_j5cWuYWwR2LB3ayuwP5bDn4TmL9jTrTE07waLIhOe5plsoVw0cSuLMmcot2yPPWTIo4jHb5J0A70sA&_hsmi=445381586&utm_content=445381586&utm_source=hs_email Stroke is a leading cause of long-term disability worldwide, leaving many survivors with persistent impairments despite advances in acute treatment and rehabilitation. A key determinant of post-stroke recovery is the brain’s ability to reorganize its structure and function following injury, known as neuroplasticity. This process involves a complex network of interacting mechanisms, including changes in synaptic connections, neural circuitry, blood vessel formation, and inflammation. However, harnessing these separate mechanisms is extremely difficult.